Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor necrosis factor receptor superfamily member 13C (TNFRSF13C), also known as BAFF-R, is the principal receptor for B-cell activating factor (BAFF). It is a type III transmembrane protein essential for B cell maturation and survival. It selectively binds to BAFF, promoting survival signals in mature B cells. Mutations or deficiencies in this gene are associated with immunodeficiency disorders.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor necrosis factor receptor superfamily member 13C (TNFRSF13C).